Blackmores Limited operates in the Medicinals and botanicals sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Blackmores Limited with three other
pharmaceutical manufacturers in Australasia:
sales of 2.98 million Australian Dollars [US$2.37 million]
(1.08 million Australian Dollars [US$857,157.83 ]
Auscann Group Holdings Ltd
(98,584.00 Australian Dollars [US$78,490.61 ]
Blackmores Limited reported sales of A$692.79 million (US$551.59 million)
June of 2017.
decrease of 3.4%
versus 2016, when the company's sales were A$717.21 million.